superantigen

Superantigens are exotoxins produced by certain bacteria that activate up to 20% of all T cells (compared to <0.01% with conventional antigens) by binding outside the normal peptide-binding groove of MHC class II molecules and the variable beta chain of the T-cell receptor, rather than requiring specific antigen presentation. This nonspecific cross-linking triggers polyclonal T-cell activation without the need for antigen specificity, resulting in a massive, uncontrolled release of pro-inflammatory cytokines (a 'cytokine storm')—notably IL-1, IL-2, IL-6, TNF-alpha, and IFN-gamma. Clinically, this manifests as toxic shock syndrome (TSS): high fever, diffuse rash, hypotension, multiorgan dysfunction, and desquamation. Classic examples include Staphylococcal enterotoxins (associated with food poisoning and TSS, often linked to tampon use or wound infections) and Toxic Shock Syndrome Toxin-1 (TSST-1) from S. aureus, as well as erythrogenic (pyrogenic) exotoxins from Streptococcus pyogenes, which cause scarlet fever and streptococcal toxic shock syndrome. Superantigens are a key concept tested on USMLE Step 1, often requiring differentiation from conventional antigen presentation and correlation with clinical toxic shock presentations. Understanding this mechanism is essential for explaining the rapid, severe systemic symptoms seen in TSS, as opposed to the localized response typical of standard immune responses.